Reasons for and Time to Discontinuation of Rimonabant Therapy

M.J.C. Willemen, A.K. Mantel-Teeuwisse, Y. Buggy, D Layton, S.M.J.M. Strauss, H.G.M. Leufkens, A.C.G. Egberts

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{fa65d51daf5d413ab724870d029f0784,

title = "Reasons for and Time to Discontinuation of Rimonabant Therapy",

author = "M.J.C. Willemen and A.K. Mantel-Teeuwisse and Y. Buggy and D Layton and S.M.J.M. Strauss and H.G.M. Leufkens and A.C.G. Egberts",

year = "2012",

language = "English",

volume = "35",

pages = "1147--1158",

journal = "Drug Safety",

issn = "0114-5916",

publisher = "Adis",

number = "12",

}